Previous Close | 7.27 |
Open | 7.27 |
Bid | 7.27 x 200 |
Ask | 7.38 x 100 |
Day's Range | 7.25 - 7.33 |
52 Week Range | 5.90 - 11.08 |
Volume | |
Avg. Volume | 166,924 |
Market Cap | 283.974M |
Beta (5Y Monthly) | 1.38 |
PE Ratio (TTM) | 29.26 |
EPS (TTM) | 0.25 |
Earnings Date | Aug 07, 2024 - Aug 12, 2024 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 13.75 |
Viemed Healthcare reports a significant revenue increase and strategic advancements, despite facing operational challenges and regulatory uncertainties.
Insight into Viemed Healthcare's First Quarter Financial Performance
LAFAYETTE, La., May 06, 2024 (GLOBE NEWSWIRE) -- Viemed Healthcare, Inc. (the “Company” or “Viemed”) (NASDAQ:VMD), a national leader in respiratory care and technology-enabled home medical equipment services, announced today that it has reported its financial results for the three months ended March 31, 2024. Operational highlights (all dollar amounts are USD): Net revenues for the quarter ended March 31, 2024 were $50.6 million, representing an increase of $11.0 million, or 28%, over net revenu